Literature DB >> 6934332

New directions in peritoneal dialysis concepts and applications.

K D Nolph, F Miller, J Rubin, R Popovich.   

Abstract

A limited number of peritoneal capillaries involved in solute exchange during peritoneal dialysis and inaccessible stagnant fluid films within the peritoneal interstitium may account for most resistance to solute transport during peritoneal dialysis. The control of small solute concentrations in blood by intermittent peritoneal dialysis will probably always require 30 to 40 hr/week of treatment even with the most rapid cycling devices. Increased understanding of factors that effect the microcirculation of the peritoneum may allow manipulation of protein losses and optimization of the long-term health of the peritoneum but will probably have little impact on the efficiency of small solute transport. CAPD accepts peritoneal dialysis as a low-efficiency system in terms of small solute clearances and yet yields similar weekly clearances to hemodialysis for small solutes by utilizing continuous dialysis. Large solute clearances with CAPD markedly exceed weekly clearances with hemodialysis.

Mesh:

Year:  1980        PMID: 6934332

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  4 in total

1.  Intercellular localization of occludins and ZO-1 as a solute transport barrier of the mesothelial monolayer.

Authors:  Ken-ichi Kaneda; Keiichi Miyamoto; Shinsuke Nomura; Takashi Horiuchi
Journal:  J Artif Organs       Date:  2006-12-21       Impact factor: 1.731

2.  Co-trimoxazole (sulphamethoxazole plus trimethoprim) peritoneal barrier transfer pharmacokinetics.

Authors:  J E Svirbely; A J Pesce; S Singh; E J O'Flaherty
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

Review 3.  Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.

Authors:  T W Paton; W R Cornish; M A Manuel; B G Hardy
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

4.  Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model.

Authors:  F Bourasset; A Dencausse; P Bourrinet; M Ducret; C Corot
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.